{"transactions":[{"id":2948827,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":144725,"kind":"person","name":"SANG CHARLES","position":1,"cik":"0001780656","reported_name":"SANG CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, External Affairs"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-11T21:00:07.000Z","date":"2020-12-11","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 1/4 of such shares on November 1, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":155000,"derivative":{"exercise_price":6.55,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-20-063102","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780656/000120919120063102/doc4.xml","form_type":"4"}},{"id":2948826,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":144725,"kind":"person","name":"SANG CHARLES","position":1,"cik":"0001780656","reported_name":"SANG CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, External Affairs"}}],"security":"Common Stock","published_at":"2020-12-11T21:00:07.000Z","date":"2020-12-11","kind":"sale","acquired":false,"shares":50000,"price":56.13,"value":2806500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $55.98 to 56.60, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-063102","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780656/000120919120063102/doc4.xml","form_type":"4"}},{"id":2948825,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":144725,"kind":"person","name":"SANG CHARLES","position":1,"cik":"0001780656","reported_name":"SANG CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, External Affairs"}}],"security":"Common Stock","published_at":"2020-12-11T21:00:07.000Z","date":"2020-12-11","kind":"exercise","acquired":true,"shares":50000,"price":6.55,"value":327500.0,"ownership":{"direct":true},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001209191-20-063102","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780656/000120919120063102/doc4.xml","form_type":"4"}},{"id":3030395,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":144725,"kind":"person","name":"SANG CHARLES","position":1,"cik":"0001780656","reported_name":"SANG CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, External Affairs"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-16T21:00:10.000Z","date":"2020-09-15","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":55000,"derivative":{"exercise_price":6.32,"expiration_date":"2026-04-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-050780","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780656/000120919120050780/doc4.xml","form_type":"4"}},{"id":3030394,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":144725,"kind":"person","name":"SANG CHARLES","position":1,"cik":"0001780656","reported_name":"SANG CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, External Affairs"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-16T21:00:10.000Z","date":"2020-09-14","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 1/4 of such shares on November 1, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":205000,"derivative":{"exercise_price":6.55,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-050780","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780656/000120919120050780/doc4.xml","form_type":"4"}},{"id":3030393,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":144725,"kind":"person","name":"SANG CHARLES","position":1,"cik":"0001780656","reported_name":"SANG CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, External Affairs"}}],"security":"Common Stock","published_at":"2020-09-16T21:00:10.000Z","date":"2020-09-15","kind":"sale","acquired":false,"shares":25000,"price":44,"value":1100000.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-050780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780656/000120919120050780/doc4.xml","form_type":"4"}},{"id":3030392,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":144725,"kind":"person","name":"SANG CHARLES","position":1,"cik":"0001780656","reported_name":"SANG CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, External Affairs"}}],"security":"Common Stock","published_at":"2020-09-16T21:00:10.000Z","date":"2020-09-15","kind":"exercise","acquired":true,"shares":25000,"price":6.32,"value":158000.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001209191-20-050780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780656/000120919120050780/doc4.xml","form_type":"4"}},{"id":3030391,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":144725,"kind":"person","name":"SANG CHARLES","position":1,"cik":"0001780656","reported_name":"SANG CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, External Affairs"}}],"security":"Common Stock","published_at":"2020-09-16T21:00:10.000Z","date":"2020-09-14","kind":"sale","acquired":false,"shares":25000,"price":42.5,"value":1062500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $42.50 to 42.51, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-050780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780656/000120919120050780/doc4.xml","form_type":"4"}},{"id":3030390,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":144725,"kind":"person","name":"SANG CHARLES","position":1,"cik":"0001780656","reported_name":"SANG CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, External Affairs"}}],"security":"Common Stock","published_at":"2020-09-16T21:00:10.000Z","date":"2020-09-14","kind":"exercise","acquired":true,"shares":25000,"price":6.55,"value":163750.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001209191-20-050780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780656/000120919120050780/doc4.xml","form_type":"4"}},{"id":3145731,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":144725,"kind":"person","name":"SANG CHARLES","position":1,"cik":"0001780656","reported_name":"SANG CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Diagnostics"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-18T21:00:13.000Z","date":"2020-05-15","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vested with respect to 1/4 of such shares on November 1, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":230000,"derivative":{"exercise_price":6.55,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-030299","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780656/000120919120030299/doc4.xml","form_type":"4"}},{"id":3145730,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":144725,"kind":"person","name":"SANG CHARLES","position":1,"cik":"0001780656","reported_name":"SANG CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Diagnostics"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-18T21:00:13.000Z","date":"2020-05-15","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":80000,"derivative":{"exercise_price":6.32,"expiration_date":"2026-04-29","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-030299","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780656/000120919120030299/doc4.xml","form_type":"4"}},{"id":3145729,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":144725,"kind":"person","name":"SANG CHARLES","position":1,"cik":"0001780656","reported_name":"SANG CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Diagnostics"}}],"security":"Common Stock","published_at":"2020-05-18T21:00:13.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":40000,"price":38.01,"value":1520400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $37.78 to 38.25, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-030299","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780656/000120919120030299/doc4.xml","form_type":"4"}},{"id":3145728,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":144725,"kind":"person","name":"SANG CHARLES","position":1,"cik":"0001780656","reported_name":"SANG CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Diagnostics"}}],"security":"Common Stock","published_at":"2020-05-18T21:00:13.000Z","date":"2020-05-15","kind":"exercise","acquired":true,"shares":20000,"price":6.55,"value":131000.0,"ownership":{"direct":true},"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001209191-20-030299","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780656/000120919120030299/doc4.xml","form_type":"4"}},{"id":3145727,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":144725,"kind":"person","name":"SANG CHARLES","position":1,"cik":"0001780656","reported_name":"SANG CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Diagnostics"}}],"security":"Common Stock","published_at":"2020-05-18T21:00:13.000Z","date":"2020-05-15","kind":"exercise","acquired":true,"shares":20000,"price":6.32,"value":126400.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-20-030299","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780656/000120919120030299/doc4.xml","form_type":"4"}},{"id":3267090,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":144725,"kind":"person","name":"SANG CHARLES","position":1,"cik":"0001780656","reported_name":"SANG CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Diagnostics"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-18T07:05:25.000Z","date":"2020-02-13","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest with respect to 1/4 of such shares on February 13, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":40000,"derivative":{"exercise_price":31.71,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-20-009863","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780656/000120919120009863/doc4.xml","form_type":"4"}}]}